As the complexity and importance of screening, testing, and individualized treatment strategies for breast cancer have increased, so has clinicians’ reliance on the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines and NCCN’s educational interventions to increase knowledge and

Management of the intact primary tumor in women presenting with stage IV breast cancer has classically been determined by the presence or absence of symptoms.

As the complexity and importance of screening, testing, and individualized treatment strategies for breast cancer have increased, so has clinicians’ reliance on the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines and NCCN’s educational interventions to increase knowledge and

Join Kristine Kokeny, MD and John Ward, MD as they present their multidisciplinary expertise on a range of cases pertaining to adjuvant systemic therapy for breast cancer.

Join Kristine Kokeny, MD and John Ward, MD as they present their multidisciplinary expertise on a range of cases pertaining to adjuvant systemic therapy for breast cancer.

The 2014 NCCN Case Manager and Medical Director Program consists of five presentations on the topics of biomarkers and targeted therapies, breast cancer, cancer survivorship, clinical trials and drug compendia, and pancreatic cancer.

Join Ingrid Mayer, MD, and Ingrid Meszoely, MD, as they present their multidisciplinary expertise on a range of cases pertaining to Breast Cancer - Advanced Disease.

Join Ingrid Mayer, MD, and Ingrid Meszoely, MD, as they present their multidisciplinary expertise on a range of cases pertaining to Breast Cancer - Advanced Disease.

This information was originally presented on March 15, 2014, at the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.

The 2014 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of five webinars on the topics of biomarkers and targeted therapies, breast cancer, cancer survivorship, clinical trials and drug compendia, and pancreatic cancer.